SynthesisLipids in health and disease2015
Increased serum resistin levels correlate with psoriasis: a meta-analysis.
Synthesis in Lipids in health and disease, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.
- Association between circulating resistin levels and thyroid dysfunction: A systematic review and meta-analysis.Frontiers in endocrinology · 2022Pooled it
- Review
- Inflammation-Related Markers in Pediatric Psoriasis: Resistin as a Potential Marker of Psoriasis Severity.Journal of clinical medicine · 2025Article
- The Intersection of the Pathogenic Processes Underlying Psoriasis and the Comorbid Condition of Obesity.Life (Basel, Switzerland) · 2024Review
- Adiponectin, Leptin and Resistin in Patients with Psoriasis.Journal of clinical medicine · 2023Article
- Can Biological Drugs Diminish the Risk of Sarcopenia in Psoriatic Patients? A Systematic Review.Life (Basel, Switzerland) · 2022Review
- Role of Fetuin-A in the Pathogenesis of Psoriasis and Its Potential Clinical Applications.Clinical, cosmetic and investigational dermatology · 2022Review
- Mast cells as important regulators in the development of psoriasis.Frontiers in immunology · 2022Review
- AntiTNF-alpha therapy normalizes levels of lipids and adipokines in psoriatic patients in the real-life settings.Scientific reports · 2021Article
- The Effect of Antioxidant and Anti-Inflammatory Capacity of Diet on Psoriasis and Psoriatic Arthritis Phenotype: Nutrition as Therapeutic Tool?Antioxidants (Basel, Switzerland) · 2021Review
- Ozonated autohemotherapy elevates PPAR-γ expression in CD4American journal of translational research · 2021Article
- Deciphering the Association Between Psoriasis and Obesity: Current Evidence and Treatment Considerations.Current obesity reports · 2020Review
- Interaction of Resistin and Systolic Blood Pressure in Psoriasis Severity.The Journal of investigative dermatology · 2020Article
- Association of circulating resistin and adiponectin levels with Kawasaki disease: A meta-analysis.Experimental and therapeutic medicine · 2020Article
- An Update on the Role of Adipose Tissues in Psoriasis.Frontiers in immunology · 2019Review
- Adipokines in psoriasis: An important link between skin inflammation and metabolic alterations.Reviews in endocrine & metabolic disorders · 2016Review
- Metabolic Syndrome and Selective Inflammatory Markers in Psoriatic Patients.Journal of immunology research · 2016Article
- Resistin serum levels and its association with clinical profile and carotid intima-media thickness in psoriasis: a cross-sectional study.Anais brasileiros de dermatologiaArticle
- Biomarkers in Psoriasis: The Future of Personalised Treatment.Indian journal of dermatologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRecent studies implicate adipokines in the pathogenesis of inflammatory diseases, including psoriasis. In this study we evaluated the significance of serum resistin levels in psoriasis patients using a meta-analysis approach.223
methodsRelevant articles were retrieved by searching the following English and Chinese databases: Cochrane Library, PubMed, Springer Link, Chinese Biomedical Database (CBM) and Chinese National Knowledge Infrastructure (CNKI). The retrieved studies were subjected to a thorough screening procedure to identify case-control studies that contained the required data. Data was extracted from each study and Version 12.0 STATA statistical software was employed for statistical analyses.
resultsNine case-control studies, containing 421 psoriasis patients and 348 healthy controls, were included in this study. The major result of the meta-analysis revealed a statistically significant association between serum resistin levels and psoriasis (SMD=2.22, 95%CI: 1.14-3.29, P<0.001). Subgroup analysis based on ethnicity showed that, compared to the healthy controls, serum resistin levels were markedly higher in psoriasis patients in both Asian and Caucasian populations (Asians: SMD=3.27, 95%CI=1.62~4.91, P<0.001; Caucasians: SMD=0.91, 95%CI=0.28~1.54, P<0.001).
conclusionsBased on our results, we conclude that serum resistin level in psoriasis patients is higher than healthy controls, and raises the possibility that elevated serum resistin levels may be a novel diagnostic marker in psoriasis and may predict the occurrence of co-morbidities in psoriasis patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.